These results highlight the restorative actions and durability of AAV-PKP2 to rescue multiple parameters associated with ARVC deficits, which resulted in prolongation of lifespan of PKP2 Hom mice, even when administered in advanced stages of ARVC. Here, PKP2 is linked to arrhythmogenic right ventricular cardiomyopathy.